Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -1 of 1
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
8/31/2006
 
First Published:
6/1/2000
1.
Phase I Study of Melanoma Vaccine Comprising Tyrosinase:368-376 Peptide, gp100:209-217 Antigen, and MART-1:26-35 Antigen Emulsified in Montanide ISA-51 Combined With Filgrastim (G-CSF)-Fetal Liver Tyrosine Kinase-3 (Flt3K) Fusion Protein in Patients With Completely Resected Stage III or IV Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
NCI
LAC-USC-10M993
LAC-USC-IRB-99B028, NCI-470, NCT00005841, 470
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute